Bristol-Myers Squibb, Celgene slide following news of delayed deal and psoriasis drug divestment - CNBC

  1. Bristol-Myers Squibb, Celgene slide following news of delayed deal and psoriasis drug divestment  CNBC
  2. Bristol-Myers Squibb Stock Is Falling as Celgene Deal Faces Setback  Barron's
  3. Bristol-Myers Will Divest Celgene Blockbuster to Close Deal  Yahoo Finance
  4. Bristol-Myers’ Celgene Deal Can Still Be a Winner  The Wall Street Journal
  5. Bristol-Myers deal to acquire Juno parent Celgene delayed amid FTC concerns  GeekWire
  6. View full coverage on Google News


from Top stories - Google News https://cnb.cx/2FsXgqk
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The court’s decision has heavy symbolic meaning, even if it may have little practical impact.

By Patrick Kingsley from NYT World https://ift.tt/8hc1Wxb